Literature DB >> 23979546

Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.

Vishnu D Gupta1.   

Abstract

A stability-indicating high-performance liquid chromatographic assay method was used to study the stabililty of cefazolin sodium (50mg/mL) in 0.9% sodium chloride injection in polypropylene syringes at 5 deg C and 25 deg C. The concentrations of the drug were directly related to peak heights, and the percent relative standard deviation based on five injections was 0.5. There were three products of decomposition that separated from the intact drug. At 5 deg C, the decomposition was less than 4% when stored for 22 days; and at 25 deg C, the loss in potency was less than 8% when stored for 7 days. When the drug was stored for 22 days at 5 deg C, its pH value increased from 5.1 to 5.3. The pH value of the injection increased from 5.1 to 5.8 when stored at 25 deg C for 7 days. The drug was not adsorbed onto the syringes, and the physical appearance of the injetion remained clear at 5 deg C and at 25 deg C during the study period.

Entities:  

Year:  2003        PMID: 23979546

Source DB:  PubMed          Journal:  Int J Pharm Compd        ISSN: 1092-4221


  3 in total

1.  Stability of cefazolin sodium in polypropylene syringes and polyvinylchloride minibags.

Authors:  Ronald F Donnelly
Journal:  Can J Hosp Pharm       Date:  2011-07

2.  Stability and Compatibility Aspects of Drugs: The Case of Selected Cephalosporins.

Authors:  Szymon Tomczak; Aleksandra Gostyńska; Malwina Nadolna; Karolina Reisner; Marta Orlando; Anna Jelińska; Maciej Stawny
Journal:  Antibiotics (Basel)       Date:  2021-05-09

3.  Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.

Authors:  Laura Herrera-Hidalgo; Rafael Luque-Márquez; Aristides de Alarcon; Ana Belén Guisado-Gil; Belen Gutierrez-Gutierrez; Maria Dolores Navarro-Amuedo; Julia Praena-Segovia; Juan Manuel Carmona-Caballero; Elena Fraile-Ramos; Alicia Gutierrez-Valencia; Luis Eduardo Lopez-Cortes; Maria Victoria Gil-Navarro
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.